{
  "article": {
    "assignment_desk_version": "v2",
    "assignment_rank": 3,
    "canonical_story_id": "47906a1f53e8a505",
    "canonical_url": "/news/story/hc_83133965ee5a16401fc438d2/",
    "cluster_manifest_ids": [
      "1788900056985736399"
    ],
    "cluster_signature": "title:ipg photonics to acquire lumibird medical for 300 million euros",
    "cluster_stream_ids": [
      "17723038993558045",
      "17806913909319771"
    ],
    "collapsed_duplicate_domains": [],
    "computed_evidence_counts": {
      "claims": 8,
      "earliest_published": "2026-09-08T00:00:00+00:00",
      "latest_published": "2026-09-08T00:00:00+00:00",
      "manifests": 1,
      "sources": 1,
      "span_hours": 0.0
    },
    "cross_domain_evidence": false,
    "dedupe_reason": "canonical public story",
    "discovery": {
      "excluded_manifest_count": 0,
      "excluded_manifest_ids": [],
      "manifest_fetch_count": 40,
      "manifest_fetch_strategy": "seed_clusters_then_high_significance",
      "mcp_window": {
        "published_date_from": "2026-09-08",
        "published_date_to": "2026-09-09"
      },
      "preflight_count": 288,
      "read_cap": 40,
      "seed_manifest_fetches": [
        {
          "excluded": 0,
          "kept": 11,
          "label": "westpac",
          "returned": 11,
          "source_channel": "westpac",
          "stream_id": "17801201634780570"
        },
        {
          "excluded": 0,
          "kept": 0,
          "label": "unknown-stream",
          "returned": 0,
          "source_channel": "goldman-sachs-exchanges",
          "stream_id": null
        },
        {
          "excluded": 0,
          "kept": 10,
          "label": "earnings-call-transcripts",
          "returned": 10,
          "source_channel": "earnings-call-transcripts",
          "stream_id": "17726302052546746"
        }
      ],
      "seed_preflights": [
        {
          "baseline_daily": 10.5,
          "count_24h": 14,
          "event_count": 0,
          "high_count": 10,
          "kind": "stream_cluster",
          "label": "westpac",
          "mcp_count": 11,
          "score": 45.33,
          "source_channel": "westpac",
          "spike_ratio": 1.33,
          "stream_id": "17801201634780570"
        },
        {
          "baseline_daily": 0.0,
          "count_24h": 12,
          "event_count": 0,
          "high_count": 6,
          "kind": "stream_cluster",
          "label": "unknown-stream",
          "mcp_count": 0,
          "score": 40.0,
          "source_channel": "goldman-sachs-exchanges",
          "spike_ratio": 12.0,
          "stream_id": null
        },
        {
          "baseline_daily": 7.928571428571429,
          "count_24h": 10,
          "event_count": 0,
          "high_count": 9,
          "kind": "stream_cluster",
          "label": "earnings-call-transcripts",
          "mcp_count": 10,
          "score": 38.26,
          "source_channel": "earnings-call-transcripts",
          "spike_ratio": 1.26,
          "stream_id": "17726302052546746"
        }
      ],
      "strict_filter": "manifest timestamp within trailing 12h"
    },
    "edition_date": "2026-09-09",
    "edition_slot": "00",
    "evidence_manifest_ids": [
      "1788900056985736399"
    ],
    "evidence_stream_ids": [
      "17723038993558045",
      "17806913909319771"
    ],
    "excluded_manifest_ids": [],
    "featured_claims": [
      {
        "claim_id": "1788902203795193332",
        "claim_ref": "03a2c7ad5476f38200ab1aa8ffad58f33fad3462",
        "headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
        "manifest_id": "1788900056985736399",
        "source_channel": "IPG Photonics SEC Filings",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm",
        "text": "The purchase price for Lumibird Medical is \u20ac300 million on a cash-free, debt-free basis."
      },
      {
        "claim_id": "1788902203807596173",
        "claim_ref": "23180f0ca2636324d375a08e8248707018e0fd8f",
        "headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
        "manifest_id": "1788900056985736399",
        "source_channel": "IPG Photonics SEC Filings",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm",
        "text": "The SPA includes a contingent earn-out of up to \u20ac50 million based on 2026 and 2027 performance metrics."
      },
      {
        "claim_id": "1788902203882717967",
        "claim_ref": "13f8a36deec8c7d923f364ee324618f73eeb25ef",
        "headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
        "manifest_id": "1788900056985736399",
        "source_channel": "IPG Photonics SEC Filings",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm",
        "text": "Closing is subject to authorization by the French Minister of the Economy and an AMF waiver."
      }
    ],
    "home_domain": "economics-business-work",
    "kind": "domain_digest",
    "lead_citations": [
      {
        "claim_id": "1788902203795193332",
        "kind": "claim",
        "manifest_id": "1788900056985736399"
      },
      {
        "claim_id": "1788902203807596173",
        "kind": "claim",
        "manifest_id": "1788900056985736399"
      }
    ],
    "meta_brief": {
      "corroborated_takeaways": 0,
      "facts": [
        {
          "disputed": false,
          "label": "Purchase Price",
          "readings": [
            {
              "manifest_id": "1788900056985736399",
              "value": "300"
            }
          ],
          "sources": 1
        },
        {
          "disputed": false,
          "label": "Contingent Earn-out",
          "readings": [
            {
              "manifest_id": "1788900056985736399",
              "value": "50"
            }
          ],
          "sources": 1
        },
        {
          "disputed": false,
          "label": "Closing",
          "readings": [
            {
              "manifest_id": "1788900056985736399",
              "value": "Q4 2026"
            }
          ],
          "sources": 1
        },
        {
          "disputed": false,
          "label": "Non-compete Duration",
          "readings": [
            {
              "manifest_id": "1788900056985736399",
              "value": "3"
            }
          ],
          "sources": 1
        }
      ],
      "manifest_count": 1,
      "open_questions": [
        {
          "manifest_ids": [
            "1788900056985736399"
          ],
          "sources": 1,
          "text": "Final regulatory approval from French Minister of the Economy"
        },
        {
          "manifest_ids": [
            "1788900056985736399"
          ],
          "sources": 1,
          "text": "Granting of AMF waiver for mandatory buyout offer"
        }
      ],
      "source_tldrs": [
        {
          "manifest_id": "1788900056985736399",
          "text": "IPG Photonics to acquire Lumibird Medical for \u20ac300M cash plus \u20ac50M earn-out, with closing expected in Q4 2026."
        }
      ],
      "stakes": [
        {
          "manifest_id": "1788900056985736399",
          "text": "This acquisition expands IPG Photonics' footprint in the medical technology sector, requiring monitoring of regulatory approvals in France and integration performance against earn-out targets."
        }
      ],
      "takeaways": [
        {
          "manifest_ids": [
            "1788900056985736399"
          ],
          "sources": 1,
          "text": "Contingent earn-out consideration of up to \u20ac50 million is tied to 2026 and 2027 performance."
        },
        {
          "manifest_ids": [
            "1788900056985736399"
          ],
          "sources": 1,
          "text": "Closing is subject to French foreign direct investment approval and an AMF waiver regarding a mandatory buyout offer."
        },
        {
          "manifest_ids": [
            "1788900056985736399"
          ],
          "sources": 1,
          "text": "The seller is subject to three-year non-solicitation and non-competition covenants post-closing."
        }
      ]
    },
    "newsworthiness_score": {
      "audience_fit": 0.85,
      "breadth": 0.529167,
      "domain_priority": 1.0,
      "materiality": 0.9,
      "novelty": 1.0,
      "source_strength": 0.85,
      "total": 0.84625
    },
    "paragraphs": [],
    "phase": "curated_synthesis",
    "primary_home_domain": "economics-business-work",
    "prompt_version": "news_editorial_v2",
    "schema_version": 1,
    "secondary_home_domains": [],
    "seed_candidates": [
      {
        "baseline_daily": 10.5,
        "count_24h": 14,
        "event_count": 0,
        "high_count": 10,
        "kind": "stream_cluster",
        "label": "westpac",
        "score": 45.33,
        "source_channel": "westpac",
        "spike_ratio": 1.33,
        "stream_id": "17801201634780570"
      },
      {
        "baseline_daily": 0.0,
        "count_24h": 12,
        "event_count": 0,
        "high_count": 6,
        "kind": "stream_cluster",
        "label": "unknown-stream",
        "score": 40.0,
        "source_channel": "goldman-sachs-exchanges",
        "spike_ratio": 12.0,
        "stream_id": null
      },
      {
        "baseline_daily": 70.42857142857143,
        "count_24h": 21,
        "event_count": 0,
        "high_count": 6,
        "kind": "stream_cluster",
        "label": "u-s-securities-and-exchange-commission",
        "score": 39.3,
        "source_channel": null,
        "spike_ratio": 0.3,
        "stream_id": null
      },
      {
        "baseline_daily": 7.928571428571429,
        "count_24h": 10,
        "event_count": 0,
        "high_count": 9,
        "kind": "stream_cluster",
        "label": "earnings-call-transcripts",
        "score": 38.26,
        "source_channel": "earnings-call-transcripts",
        "spike_ratio": 1.26,
        "stream_id": "17726302052546746"
      },
      {
        "baseline_daily": 0.07142857142857142,
        "count_24h": 14,
        "event_count": 0,
        "high_count": 4,
        "kind": "stream_cluster",
        "label": "unknown-stream",
        "score": 36.0,
        "source_channel": "natwest-bondcast-podcast",
        "spike_ratio": 140.0,
        "stream_id": null
      },
      {
        "baseline_daily": 5.071428571428571,
        "count_24h": 8,
        "event_count": 0,
        "high_count": 8,
        "kind": "stream_cluster",
        "label": "westpac-iq",
        "score": 33.58,
        "source_channel": null,
        "spike_ratio": 1.58,
        "stream_id": null
      },
      {
        "baseline_daily": 0.0,
        "count_24h": 8,
        "event_count": 0,
        "high_count": 5,
        "kind": "stream_cluster",
        "label": "unknown-stream",
        "score": 31.0,
        "source_channel": "goldman-sachs-the-markets",
        "spike_ratio": 8.0,
        "stream_id": null
      },
      {
        "baseline_daily": 0.0,
        "count_24h": 12,
        "event_count": 0,
        "high_count": 3,
        "kind": "stream_cluster",
        "label": "unknown-stream",
        "score": 31.0,
        "source_channel": "ing-think-reports",
        "spike_ratio": 12.0,
        "stream_id": null
      },
      {
        "baseline_daily": 0.0,
        "count_24h": 10,
        "event_count": 0,
        "high_count": 3,
        "kind": "stream_cluster",
        "label": "unknown-stream",
        "score": 29.0,
        "source_channel": "jpmorgan-podcast",
        "spike_ratio": 10.0,
        "stream_id": null
      },
      {
        "baseline_daily": 0.0,
        "count_24h": 8,
        "event_count": 0,
        "high_count": 4,
        "kind": "stream_cluster",
        "label": "central-bank-of-bolivia",
        "score": 28.0,
        "source_channel": "central-bank-of-bolivia",
        "spike_ratio": 8.0,
        "stream_id": "17807977095319963"
      },
      {
        "baseline_daily": 0.14285714285714285,
        "count_24h": 8,
        "event_count": 0,
        "high_count": 3,
        "kind": "stream_cluster",
        "label": "unknown-stream",
        "score": 27.0,
        "source_channel": "mufg-global-markets-podcast",
        "spike_ratio": 56.0,
        "stream_id": null
      },
      {
        "baseline_daily": 0.0,
        "count_24h": 7,
        "event_count": 0,
        "high_count": 3,
        "kind": "stream_cluster",
        "label": "unknown-stream",
        "score": 23.0,
        "source_channel": "tbpn",
        "spike_ratio": 7.0,
        "stream_id": null
      }
    ],
    "slug": "00-3-ipg-photonics-lumibird-medical-acquisition",
    "source_manifests": [
      {
        "brief": {
          "facts": [
            {
              "label": "Purchase Price",
              "value": "300"
            },
            {
              "label": "Contingent Earn-out",
              "value": "50"
            },
            {
              "label": "Closing",
              "value": "Q4 2026"
            },
            {
              "label": "Non-compete Duration",
              "value": "3"
            }
          ],
          "key_insights": [
            "Contingent earn-out consideration of up to \u20ac50 million is tied to 2026 and 2027 performance.",
            "Closing is subject to French foreign direct investment approval and an AMF waiver regarding a mandatory buyout offer.",
            "The seller is subject to three-year non-solicitation and non-competition covenants post-closing."
          ],
          "tldr": "IPG Photonics to acquire Lumibird Medical for \u20ac300M cash plus \u20ac50M earn-out, with closing expected in Q4 2026.",
          "unresolved": [
            "Final regulatory approval from French Minister of the Economy",
            "Granting of AMF waiver for mandatory buyout offer"
          ],
          "why_it_matters": "This acquisition expands IPG Photonics' footprint in the medical technology sector, requiring monitoring of regulatory approvals in France and integration performance against earn-out targets."
        },
        "claim_count": 8,
        "claims": [
          {
            "claim_id": "1788902203761887463",
            "claim_ref": "66475cc90994320f02fc25237f65ed99d728ff95",
            "snapshot": "{\"claim_id\":\"1788902203761887463\",\"claim_text\":\"IPG Photonics entered into a share purchase agreement to acquire 100% of Lumibird Medical.\",\"claim_type\":\"event\",\"confidence\":\"stated\",\"entities\":[{\"name\":\"IPG Photonics Corporation\",\"role\":\"source_org\",\"tag_id\":\"17731244519880090\",\"type\":\"organization\"},{\"name\":\"Lumibird Medical\",\"role\":\"subject\",\"tag_id\":\"17842846352282573\",\"type\":\"organization\"}],\"evidence\":\"direct_quote\",\"featured\":true,\"key_point_index\":0,\"quote\":\"on September 8, 2026, the Company and the Seller entered into a share purchase agreement... governing the sale of the shares of Lumibird Medical to the Company\",\"signal\":\"Track the completion of this acquisition as a material change to IPG Photonics' business portfolio.\",\"source_urls\":[],\"supporting_quotes\":[]}",
            "text": "IPG Photonics entered into a share purchase agreement to acquire 100% of Lumibird Medical."
          },
          {
            "claim_id": "1788902203795193332",
            "claim_ref": "03a2c7ad5476f38200ab1aa8ffad58f33fad3462",
            "snapshot": "{\"claim_id\":\"1788902203795193332\",\"claim_text\":\"The purchase price for Lumibird Medical is \\u20ac300 million on a cash-free, debt-free basis.\",\"claim_type\":\"data\",\"confidence\":\"measured\",\"entities\":[{\"name\":\"IPG Photonics Corporation\",\"role\":\"source_org\",\"tag_id\":\"17731244519880090\",\"type\":\"organization\"}],\"evidence\":\"direct_quote\",\"featured\":true,\"key_point_index\":0,\"quote\":\"The SPA provides for the Acquisition for a purchase price of \\u20ac300 million on a cash-free, debt-free basis\",\"signal\":\"Update financial models for IPG Photonics to reflect the cash outflow and potential asset integration.\",\"source_urls\":[],\"supporting_quotes\":[]}",
            "text": "The purchase price for Lumibird Medical is \u20ac300 million on a cash-free, debt-free basis."
          },
          {
            "claim_id": "1788902203807596173",
            "claim_ref": "23180f0ca2636324d375a08e8248707018e0fd8f",
            "snapshot": "{\"claim_id\":\"1788902203807596173\",\"claim_text\":\"The SPA includes a contingent earn-out of up to \\u20ac50 million based on 2026 and 2027 performance metrics.\",\"claim_type\":\"data\",\"confidence\":\"stated\",\"entities\":[{\"name\":\"IPG Photonics Corporation\",\"role\":\"source_org\",\"tag_id\":\"17731244519880090\",\"type\":\"organization\"}],\"evidence\":\"direct_quote\",\"featured\":true,\"key_point_index\":1,\"quote\":\"The SPA also provides for contingent earn-out consideration of up to \\u20ac50 million in additional cash based on the achievement of certain 2026 and 2027 performance metrics.\",\"signal\":\"Monitor future earnings reports for potential earn-out payments and performance milestones.\",\"source_urls\":[],\"supporting_quotes\":[]}",
            "text": "The SPA includes a contingent earn-out of up to \u20ac50 million based on 2026 and 2027 performance metrics."
          },
          {
            "claim_id": "1788902203865127401",
            "claim_ref": "f94756ae7dd00dd93ff96153de4e2e7b265992db",
            "snapshot": "{\"claim_id\":\"1788902203865127401\",\"claim_text\":\"The seller is subject to non-solicitation and non-competition undertakings for three years following the closing.\",\"claim_type\":\"statement\",\"confidence\":\"stated\",\"entities\":[{\"name\":\"Lumibird S.A.\",\"role\":\"subject\",\"tag_id\":\"17843176583267543\",\"type\":\"organization\"}],\"evidence\":\"direct_quote\",\"featured\":true,\"key_point_index\":3,\"quote\":\"The SPA also contains customary covenants of the parties, including non-solicitation and non-competition undertakings of the Seller for three years following the closing\",\"signal\":\"Assess the competitive landscape and potential for seller-led competition post-acquisition.\",\"source_urls\":[],\"supporting_quotes\":[]}",
            "text": "The seller is subject to non-solicitation and non-competition undertakings for three years following the closing."
          },
          {
            "claim_id": "1788902203882717967",
            "claim_ref": "13f8a36deec8c7d923f364ee324618f73eeb25ef",
            "snapshot": "{\"claim_id\":\"1788902203882717967\",\"claim_text\":\"Closing is subject to authorization by the French Minister of the Economy and an AMF waiver.\",\"claim_type\":\"statement\",\"confidence\":\"stated\",\"entities\":[{\"name\":\"French Minister of the Economy\",\"role\":\"mentioned\",\"tag_id\":\"17730925059721587\",\"type\":\"organization\"},{\"name\":\"Autorit\\u00e9 des march\\u00e9s financiers\",\"role\":\"mentioned\",\"tag_id\":\"17724043973368491\",\"type\":\"organization\"}],\"evidence\":\"direct_quote\",\"featured\":true,\"key_point_index\":2,\"quote\":\"The parties' obligations to complete the Acquisition are subject to certain customary conditions and approvals, including authorization by the French Minister of the Economy... and the French securities regulator (the Autorit\\u00e9 des march\\u00e9s financiers, or \\\"AMF\\\") granting a waiver\",\"signal\":\"Monitor regulatory filings in France for updates on these specific approvals.\",\"source_urls\":[],\"supporting_quotes\":[]}",
            "text": "Closing is subject to authorization by the French Minister of the Economy and an AMF waiver."
          },
          {
            "claim_id": "1788902203822751980",
            "claim_ref": "8ff0fb2a95e60165cce832383af5f4e9afdea00c",
            "snapshot": "{\"claim_id\":\"1788902203822751980\",\"claim_text\":\"The acquisition is expected to close in the fourth quarter of 2026.\",\"claim_type\":\"forecast\",\"confidence\":\"stated\",\"entities\":[{\"name\":\"IPG Photonics Corporation\",\"role\":\"source_org\",\"tag_id\":\"17731244519880090\",\"type\":\"organization\"}],\"evidence\":\"direct_quote\",\"featured\":false,\"key_point_index\":null,\"quote\":\"The closing of the Acquisition is expected to occur in the fourth quarter of 2026.\",\"signal\":\"Update project timelines for the integration of Lumibird Medical into IPG Photonics.\",\"source_urls\":[],\"supporting_quotes\":[]}",
            "text": "The acquisition is expected to close in the fourth quarter of 2026."
          },
          {
            "claim_id": "1788902203930896885",
            "claim_ref": "f35adc84fceb8e87f75bc172bd558e210ee631c8",
            "snapshot": "{\"claim_id\":\"1788902203930896885\",\"claim_text\":\"IPG Photonics secured a warranty and indemnity insurance policy for the acquisition.\",\"claim_type\":\"event\",\"confidence\":\"stated\",\"entities\":[{\"name\":\"IPG Photonics Corporation\",\"role\":\"source_org\",\"tag_id\":\"17731244519880090\",\"type\":\"organization\"}],\"evidence\":\"direct_quote\",\"featured\":false,\"key_point_index\":null,\"quote\":\"In connection with the Acquisition, the Company has secured a warranty and indemnity insurance policy (the \\\" W&I Policy \\\")\",\"signal\":\"Note the risk mitigation strategy employed by IPG Photonics for this transaction.\",\"source_urls\":[],\"supporting_quotes\":[]}",
            "text": "IPG Photonics secured a warranty and indemnity insurance policy for the acquisition."
          },
          {
            "claim_id": "1788902203959133256",
            "claim_ref": "9f372cde8e6a233a2327763cd50d4dee8b99069d",
            "snapshot": "{\"claim_id\":\"1788902203959133256\",\"claim_text\":\"IPG Photonics expects to fund the acquisition through cash on hand.\",\"claim_type\":\"statement\",\"confidence\":\"stated\",\"entities\":[{\"name\":\"IPG Photonics Corporation\",\"role\":\"source_org\",\"tag_id\":\"17731244519880090\",\"type\":\"organization\"}],\"evidence\":\"direct_quote\",\"featured\":false,\"key_point_index\":null,\"quote\":\"The Company expects to fund the Acquisition through cash on hand.\",\"signal\":\"Assess the impact of this cash expenditure on IPG Photonics' liquidity and capital allocation strategy.\",\"source_urls\":[],\"supporting_quotes\":[]}",
            "text": "IPG Photonics expects to fund the acquisition through cash on hand."
          }
        ],
        "entities": [],
        "headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
        "home_domain": null,
        "manifest_id": "1788900056985736399",
        "published_at": "2026-09-08",
        "significance": "high",
        "source_channel": "IPG Photonics SEC Filings",
        "source_name": "sec-company-0001111928",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm",
        "stream_id": null,
        "stream_ids": [
          "17723038993558045",
          "17806913909319771"
        ],
        "summary": "IPG Photonics Corporation has entered into a definitive share purchase agreement to acquire 100% of Lumibird Medical from Lumibird S.A. for a cash purchase price of \u20ac300 million. The deal includes a potential earn-out of up to \u20ac50 million based on 2026 and 2027 performance metrics. The acquisition is expected to close in the fourth quarter of 2026, pending French regulatory approvals and other customary conditions.",
        "tags": [
          "United States Securities and Exchange Commission",
          "IPG Photonics",
          "Lumibird Medical",
          "Lumibird S.A."
        ]
      }
    ],
    "stories_per_domain": 24,
    "story_attempt": 1,
    "story_slot": 3,
    "story_units": [
      {
        "paragraphs": [
          {
            "citations": [
              {
                "claim_id": "1788902203761887463",
                "kind": "claim",
                "manifest_id": "1788900056985736399"
              },
              {
                "claim_id": "1788902203822751980",
                "kind": "claim",
                "manifest_id": "1788900056985736399"
              }
            ],
            "text": "IPG Photonics has signed an agreement to acquire 100% of Lumibird Medical. The deal is expected to close in the fourth quarter of 2026, marking a significant expansion of the company's footprint in the medical technology sector."
          },
          {
            "citations": [
              {
                "claim_id": "1788902203795193332",
                "kind": "claim",
                "manifest_id": "1788900056985736399"
              },
              {
                "claim_id": "1788902203959133256",
                "kind": "claim",
                "manifest_id": "1788900056985736399"
              },
              {
                "claim_id": "1788902203807596173",
                "kind": "claim",
                "manifest_id": "1788900056985736399"
              },
              {
                "claim_id": "1788902203930896885",
                "kind": "claim",
                "manifest_id": "1788900056985736399"
              },
              {
                "claim_id": "1788902203865127401",
                "kind": "claim",
                "manifest_id": "1788900056985736399"
              }
            ],
            "text": "The purchase price is \u20ac300 million on a cash-free, debt-free basis, which IPG Photonics plans to fund using cash on hand. The agreement also includes a contingent earn-out of up to \u20ac50 million, which is tied to performance metrics in 2026 and 2027. To protect the investment, IPG Photonics secured a warranty and indemnity insurance policy, while the seller agreed to non-solicitation and non-competition terms for three years after closing."
          },
          {
            "citations": [
              {
                "claim_id": "1788902203882717967",
                "kind": "claim",
                "manifest_id": "1788900056985736399"
              }
            ],
            "text": "Before the acquisition can close, it must clear regulatory hurdles in France. The deal requires authorization from the French Minister of the Economy, alongside an AMF waiver regarding a mandatory buyout offer."
          }
        ],
        "single_source": true,
        "title": "IPG Photonics Expands Medical Footprint"
      }
    ],
    "summary": "IPG Photonics has agreed to purchase Lumibird Medical for 300 million euros in a cash-funded deal that includes a potential 50 million euro earn-out.",
    "supply": {
      "briefs": 356,
      "manifests": 551,
      "mcp_servable": 260,
      "signals": 356
    },
    "supporting_evidence": [],
    "supporting_home_domains": [],
    "supporting_manifest_ids": [],
    "supporting_stream_ids": [],
    "tail": [],
    "title": "IPG Photonics to Acquire Lumibird Medical for 300 Million Euros",
    "window": {
      "hours": 12,
      "since": "2026-09-08T12:30:02.688278+00:00",
      "until": "2026-09-09T00:30:02.688278+00:00"
    }
  },
  "canonical_story_id": "47906a1f53e8a505",
  "citation_ledger": {
    "assignment": {
      "assignment_desk_version": "v2",
      "assignment_rank": 3,
      "canonical_story_id": "hc_83133965ee5a16401fc438d2",
      "canonical_url": "/news/story/hc_83133965ee5a16401fc438d2/",
      "cluster_manifest_ids": [
        "1788900056985736399"
      ],
      "cluster_signature": "hcsig_v1_f9898eb4567d9099af58e816dcd19eb18f507ce77a7daa49e7ad6cde1a20cd0c",
      "cluster_stream_ids": [
        "17723038993558045",
        "17806913909319771"
      ],
      "cross_domain_evidence": false,
      "dedupe_reason": "global prewrite assignment",
      "evidence_manifest_ids": [
        "1788900056985736399"
      ],
      "evidence_stream_ids": [
        "17723038993558045",
        "17806913909319771"
      ],
      "newsworthiness_score": {
        "audience_fit": 0.85,
        "breadth": 0.529167,
        "domain_priority": 1.0,
        "materiality": 0.9,
        "novelty": 1.0,
        "source_strength": 0.85,
        "total": 0.84625
      },
      "primary_home_domain": "economics-business-work",
      "secondary_home_domains": [
        "engineering-technology",
        "society-law-government"
      ],
      "supporting_evidence": [],
      "supporting_home_domains": [],
      "supporting_manifest_ids": [],
      "supporting_stream_ids": []
    },
    "assignment_prefetch_billed_manifests": 56,
    "calls": [
      {
        "billed_manifests": 0,
        "called_at": "2026-09-09T00:32:15.095767+00:00",
        "elapsed_ms": 364.21,
        "manifest_ids": [],
        "mode": "count",
        "payload_bytes": 978206,
        "tool": "synorb-manifests"
      },
      {
        "billed_manifests": 0,
        "called_at": "2026-09-09T00:32:15.246362+00:00",
        "elapsed_ms": 148.18,
        "manifest_ids": [],
        "mode": "count",
        "payload_bytes": 280611,
        "tool": "synorb-manifests"
      },
      {
        "billed_manifests": 0,
        "called_at": "2026-09-09T00:32:19.653472+00:00",
        "elapsed_ms": 4406.27,
        "manifest_ids": [],
        "mode": "count",
        "payload_bytes": 82441,
        "tool": "synorb-manifests"
      },
      {
        "billed_manifests": 0,
        "called_at": "2026-09-09T00:32:19.811233+00:00",
        "elapsed_ms": 154.73,
        "manifest_ids": [],
        "mode": "count",
        "payload_bytes": 330133,
        "tool": "synorb-manifests"
      },
      {
        "billed_manifests": 11,
        "called_at": "2026-09-09T00:32:20.008027+00:00",
        "elapsed_ms": 192.94,
        "manifest_ids": [
          "1788890315868662495",
          "1788890315868134981",
          "1788890315867932712",
          "1788890315867694414",
          "1788890315867684978",
          "1788890315867675201",
          "1788890315867623585",
          "1788890315866521766",
          "1788878772594940014",
          "1788878772594772265",
          "1788878772586412029"
        ],
        "mode": "default",
        "payload_bytes": 474000,
        "tool": "synorb-manifests"
      },
      {
        "billed_manifests": 0,
        "called_at": "2026-09-09T00:32:20.332653+00:00",
        "elapsed_ms": 322.59,
        "manifest_ids": [],
        "mode": "default",
        "payload_bytes": 80594,
        "tool": "synorb-manifests"
      },
      {
        "billed_manifests": 10,
        "called_at": "2026-09-09T00:32:20.584832+00:00",
        "elapsed_ms": 247.35,
        "manifest_ids": [
          "1788910483679999330",
          "1788910483679816895",
          "1788910483679320563",
          "1788910483678553542",
          "1788910483678059937",
          "1788910483670254621",
          "1788877071898860324",
          "1788877071898522092",
          "1788871438255116452",
          "1788871438254487674"
        ],
        "mode": "default",
        "payload_bytes": 591459,
        "tool": "synorb-manifests"
      },
      {
        "billed_manifests": 35,
        "called_at": "2026-09-09T00:32:21.081289+00:00",
        "elapsed_ms": 479.92,
        "manifest_ids": [
          "1788911135167355990",
          "1788910483679999330",
          "1788910483679816895",
          "1788910483679320563",
          "1788910483678553542",
          "1788910483670254621",
          "1788909114751331852",
          "1788906858542014833",
          "1788904280566485311",
          "1788903057752725508",
          "1788902618695089498",
          "1788902004737056158",
          "1788901515751424306",
          "1788901143519606885",
          "1788900930665445948",
          "1788900081617332104",
          "1788900056985736399",
          "1788898877118913417",
          "1788896904275644644",
          "1788896616258159208",
          "1788895727566619038",
          "1788895371981481897",
          "1788894959203829762",
          "1788894808445110173",
          "1788894568515250909",
          "1788893071819938274",
          "1788892666797701831",
          "1788891565096501285",
          "1788891565095978629",
          "1788891565095481026",
          "1788890315868662495",
          "1788890315868134981",
          "1788890315867932712",
          "1788890315867694414",
          "1788890315867684978",
          "1788890315867675201",
          "1788890315867623585",
          "1788890315866521766",
          "1788890096582939911",
          "1788889605026007527"
        ],
        "mode": "default",
        "payload_bytes": 1972958,
        "tool": "synorb-manifests"
      }
    ],
    "distinct_manifest_ids": [
      "1788900056985736399"
    ],
    "edition_slot": "00",
    "excluded_manifest_ids": [],
    "prompt_version": "news_editorial_v2",
    "run_started_at": "2026-09-09T00:32:14.706674+00:00",
    "stories_per_domain": 24,
    "story_slot": 3,
    "strict_window": {
      "client_filtered": true,
      "published_date_from": "2026-09-08T12:30:02.688278+00:00",
      "published_date_to": "2026-09-09T00:30:02.688278+00:00"
    },
    "total_billed_manifests": 1,
    "total_calls": 8,
    "total_payload_bytes": 4790402
  },
  "cluster_manifest_ids": [
    "1788900056985736399"
  ],
  "cluster_signature": "title:ipg photonics to acquire lumibird medical for 300 million euros",
  "corrections": [],
  "dedupe_reason": "canonical public story",
  "edition_date": "2026-09-09",
  "fact_claim_map": [
    {
      "claims": [
        {
          "claim_id": "1788902203761887463",
          "claim_ref": "66475cc90994320f02fc25237f65ed99d728ff95",
          "claim_text": "IPG Photonics entered into a share purchase agreement to acquire 100% of Lumibird Medical.",
          "kind": "claim",
          "manifest_headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
          "manifest_id": "1788900056985736399",
          "mcp_url": "https://synorb.com/agents?manifest_id=1788900056985736399&utm_source=hangingcontext&utm_medium=news_citation&utm_campaign=hc_news_public",
          "number": 1,
          "source_name": "IPG Photonics SEC Filings",
          "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm"
        },
        {
          "claim_id": "1788902203822751980",
          "claim_ref": "8ff0fb2a95e60165cce832383af5f4e9afdea00c",
          "claim_text": "The acquisition is expected to close in the fourth quarter of 2026.",
          "kind": "claim",
          "manifest_headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
          "manifest_id": "1788900056985736399",
          "mcp_url": "https://synorb.com/agents?manifest_id=1788900056985736399&utm_source=hangingcontext&utm_medium=news_citation&utm_campaign=hc_news_public",
          "number": 2,
          "source_name": "IPG Photonics SEC Filings",
          "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm"
        }
      ],
      "paragraph": 1,
      "text": "IPG Photonics has signed an agreement to acquire 100% of Lumibird Medical. The deal is expected to close in the fourth quarter of 2026, marking a significant expansion of the company's footprint in the medical technology sector."
    },
    {
      "claims": [
        {
          "claim_id": "1788902203795193332",
          "claim_ref": "03a2c7ad5476f38200ab1aa8ffad58f33fad3462",
          "claim_text": "The purchase price for Lumibird Medical is \u20ac300 million on a cash-free, debt-free basis.",
          "kind": "claim",
          "manifest_headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
          "manifest_id": "1788900056985736399",
          "mcp_url": "https://synorb.com/agents?manifest_id=1788900056985736399&utm_source=hangingcontext&utm_medium=news_citation&utm_campaign=hc_news_public",
          "number": 3,
          "source_name": "IPG Photonics SEC Filings",
          "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm"
        },
        {
          "claim_id": "1788902203959133256",
          "claim_ref": "9f372cde8e6a233a2327763cd50d4dee8b99069d",
          "claim_text": "IPG Photonics expects to fund the acquisition through cash on hand.",
          "kind": "claim",
          "manifest_headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
          "manifest_id": "1788900056985736399",
          "mcp_url": "https://synorb.com/agents?manifest_id=1788900056985736399&utm_source=hangingcontext&utm_medium=news_citation&utm_campaign=hc_news_public",
          "number": 4,
          "source_name": "IPG Photonics SEC Filings",
          "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm"
        },
        {
          "claim_id": "1788902203807596173",
          "claim_ref": "23180f0ca2636324d375a08e8248707018e0fd8f",
          "claim_text": "The SPA includes a contingent earn-out of up to \u20ac50 million based on 2026 and 2027 performance metrics.",
          "kind": "claim",
          "manifest_headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
          "manifest_id": "1788900056985736399",
          "mcp_url": "https://synorb.com/agents?manifest_id=1788900056985736399&utm_source=hangingcontext&utm_medium=news_citation&utm_campaign=hc_news_public",
          "number": 5,
          "source_name": "IPG Photonics SEC Filings",
          "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm"
        },
        {
          "claim_id": "1788902203930896885",
          "claim_ref": "f35adc84fceb8e87f75bc172bd558e210ee631c8",
          "claim_text": "IPG Photonics secured a warranty and indemnity insurance policy for the acquisition.",
          "kind": "claim",
          "manifest_headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
          "manifest_id": "1788900056985736399",
          "mcp_url": "https://synorb.com/agents?manifest_id=1788900056985736399&utm_source=hangingcontext&utm_medium=news_citation&utm_campaign=hc_news_public",
          "number": 6,
          "source_name": "IPG Photonics SEC Filings",
          "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm"
        },
        {
          "claim_id": "1788902203865127401",
          "claim_ref": "f94756ae7dd00dd93ff96153de4e2e7b265992db",
          "claim_text": "The seller is subject to non-solicitation and non-competition undertakings for three years following the closing.",
          "kind": "claim",
          "manifest_headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
          "manifest_id": "1788900056985736399",
          "mcp_url": "https://synorb.com/agents?manifest_id=1788900056985736399&utm_source=hangingcontext&utm_medium=news_citation&utm_campaign=hc_news_public",
          "number": 7,
          "source_name": "IPG Photonics SEC Filings",
          "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm"
        }
      ],
      "paragraph": 2,
      "text": "The purchase price is \u20ac300 million on a cash-free, debt-free basis, which IPG Photonics plans to fund using cash on hand. The agreement also includes a contingent earn-out of up to \u20ac50 million, which is tied to performance metrics in 2026 and 2027. To protect the investment, IPG Photonics secured a warranty and indemnity insurance policy, while the seller agreed to non-solicitation and non-competition terms for three years after closing."
    },
    {
      "claims": [
        {
          "claim_id": "1788902203882717967",
          "claim_ref": "13f8a36deec8c7d923f364ee324618f73eeb25ef",
          "claim_text": "Closing is subject to authorization by the French Minister of the Economy and an AMF waiver.",
          "kind": "claim",
          "manifest_headline": "IPG Photonics files 8-K: Enters agreement to acquire Lumibird Medical for \u20ac300 million",
          "manifest_id": "1788900056985736399",
          "mcp_url": "https://synorb.com/agents?manifest_id=1788900056985736399&utm_source=hangingcontext&utm_medium=news_citation&utm_campaign=hc_news_public",
          "number": 8,
          "source_name": "IPG Photonics SEC Filings",
          "source_url": "https://www.sec.gov/Archives/edgar/data/1111928/000111192826000169/ipgp-20260908.htm"
        }
      ],
      "paragraph": 3,
      "text": "Before the acquisition can close, it must clear regulatory hurdles in France. The deal requires authorization from the French Minister of the Economy, alongside an AMF waiver regarding a mandatory buyout offer."
    }
  ],
  "gate_report": {
    "checked_at": "2026-09-09T00:30:02.688278+00:00",
    "deterministic_pass": true,
    "findings": [],
    "judge": {
      "cost_usd": 0.002698,
      "model": "gemini-3.1-flash-lite",
      "sentences": [
        {
          "classification": "factual",
          "reason": "The purchase price and the contingent earn-out are directly supported by the cited claims.",
          "sentence": "IPG Photonics to Acquire Lumibird Medical for 300 Million Euros IPG Photonics has agreed to purchase Lumibird Medical for 300 million euros in a cash-funded deal that includes a potential 50 million euro earn-out.",
          "verdict": "entailed"
        },
        {
          "classification": "factual",
          "reason": "The cited claims confirm IPG Photonics entered into a share purchase agreement to acquire 100% of the company.",
          "sentence": "IPG Photonics has signed an agreement to acquire 100% of Lumibird Medical.",
          "verdict": "entailed"
        },
        {
          "classification": "factual",
          "reason": "The closing date is directly supported by the cited claims, while the expansion description is framing.",
          "sentence": "The deal is expected to close in the fourth quarter of 2026, marking a significant expansion of the company's footprint in the medical technology sector.",
          "verdict": "entailed"
        },
        {
          "classification": "factual",
          "reason": "The purchase price and funding method are directly supported by the cited claims.",
          "sentence": "The purchase price is \u20ac300 million on a cash-free, debt-free basis, which IPG Photonics plans to fund using cash on hand.",
          "verdict": "entailed"
        },
        {
          "classification": "factual",
          "reason": "The earn-out amount and the performance metrics timeline are directly supported by the cited claims.",
          "sentence": "The agreement also includes a contingent earn-out of up to \u20ac50 million, which is tied to performance metrics in 2026 and 2027.",
          "verdict": "entailed"
        },
        {
          "classification": "factual",
          "reason": "The insurance policy and the non-solicitation/non-competition terms are directly supported by the cited claims.",
          "sentence": "To protect the investment, IPG Photonics secured a warranty and indemnity insurance policy, while the seller agreed to non-solicitation and non-competition terms for three years after closing.",
          "verdict": "entailed"
        },
        {
          "classification": "factual",
          "reason": "The requirement for authorization from French authorities is directly supported by the cited claims.",
          "sentence": "Before the acquisition can close, it must clear regulatory hurdles in France.",
          "verdict": "entailed"
        },
        {
          "classification": "factual",
          "reason": "The specific regulatory requirements are directly supported by the cited claims.",
          "sentence": "The deal requires authorization from the French Minister of the Economy, alongside an AMF waiver regarding a mandatory buyout offer.",
          "verdict": "entailed"
        }
      ],
      "status": "pass",
      "tokens_in": 1138,
      "tokens_out": 698
    },
    "metrics": {
      "cited_manifests": 1,
      "claims_available": 8,
      "lead_checked": true,
      "paragraphs_checked": 3
    },
    "rewrite_attempted": false,
    "status": "passed",
    "version": "news_pr_d_v2"
  },
  "home_domain": "economics-business-work",
  "lastmod": "2026-09-09",
  "primary_home_domain": "economics-business-work",
  "schema_version": 1,
  "secondary_home_domains": [],
  "status": "draft",
  "summary": "IPG Photonics has agreed to purchase Lumibird Medical for 300 million euros in a cash-funded deal that includes a potential 50 million euro earn-out.",
  "suppressed_duplicate_of": null,
  "title": "IPG Photonics to Acquire Lumibird Medical for 300 Million Euros",
  "url": "https://hangingcontext.com/news/economics-business-work/2026-09-09-00-3-ipg-photonics-lumibird-medical-acquisition/"
}